Clinical Trial Update: Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics of oral omadacycline in adults with community-acquired pneumonia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Omadacycline (omadacycline)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Community-acquired Pneumonia | Phase 1 | Status: COMPLETED | Results posted: 2021-11-03